Black Diamond Therapeutics所有资讯

Black Diamond Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-T. Rowe Price Investment Management, Inc.(19.0%)

11/14 13:34 (美东)

Black Diamond Therapeutics | SC 13G：超过5%持股股东披露文件-Vestal Point Capital, LP(8.9%),Ryan Wilder(8.9%)

11/14 12:08 (美东)

Black Diamond Therapeutics | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(6.2%)

11/08 14:20 (美东)

Black Diamond Therapeutics | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(6.2%)

10/24 14:06 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Behbahani Ali

09/20 16:34 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Campbell Shannon

09/20 16:27 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Raman Prakash

09/20 16:27 (美东)

Black Diamond Therapeutics | 4：持股变动声明-股东 Versant Venture Capital VI, L.P.

08/30 16:19 (美东)

Black Diamond Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Versant Ventures VI GP, L.P.(7.7%),Versant Ventures VI GP-GP, LLC(7.7%)等

08/08 16:50 (美东)

Black Diamond Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-T. Rowe Price Investment Management, Inc.(18.9%)

07/10 14:18 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Behbahani Ali

06/21 16:29 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Raman Prakash

06/21 16:26 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Campbell Shannon

06/21 16:24 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Behbahani Ali

06/06 18:22 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Kulkarni Samarth

06/06 17:57 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Menzel Garry E

06/06 17:57 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Raman Prakash

06/06 17:57 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Campbell Shannon

06/06 17:57 (美东)

Black Diamond Therapeutics | 4：持股变动声明-董事 Dhingra Kapil

06/06 17:52 (美东)

Black Diamond Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-Ali Behbahani(8.1%),New Enterprise Associates 16, L.P.(7.9%)等

05/13 19:14 (美东)